Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India-Reference-Cited by-同舟云学术

Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India

Published:2019-02-11 Issue:5 Volume:74 Page:1260-1268
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Singh Ashutosh¹,Singh Pradeep K¹,de Groot Theun²,Kumar Anil³,Mathur Purva⁴,Tarai Bansidhar⁵,Sachdeva Neelam⁶,Upadhyaya Gargi¹,Sarma Smita⁷,Meis Jacques F²⁸,Chowdhary Anuradha¹

Affiliation:

1. Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India

2. Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital (CWZ), Nijmegen, The Netherlands

3. Department of Microbiology, Amrita Institute of Medical Sciences and Research Center, Vishwa Vidyapeetham, Ponekkara, Cochin, India

4. Department of Laboratory Medicine, Jai Prakash Narayan Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi, India

5. Department of Microbiology, Max Hospital, New Delhi, India

6. Department of Microbiology, Rajiv Gandhi Cancer Institute & Research Center, Delhi, India

7. Department of Microbiology, Medanta-The Medcity, Gurgaon, Haryana, India

8. Centre of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands

Funder

Council of Scientific & Industrial Research

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/5/1260/28501097/dkz029.pdf

Reference52 articles.

2. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the prospective antifungal therapy (PATH) registry 2004–2008;Pfaller;PLoS One,2014

3. Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002–2012;Strollo;Emerg Infect Dis,2017

4. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities;Wisplinghoff;Int J Antimicrob Agents,2014

5. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003;Almirante;J Clin Microbiol,2005

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “A decade of candidaemia: A comprehensive analysis of prognosis and risk factors at a Belgian tertiary hospital”;Diagnostic Microbiology and Infectious Disease;2024-11

2. Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens list;Medical Mycology;2024-06

3. COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance;Medical Mycology;2024-03-23

4. Fluconazole‐resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole‐resistance profiles associated with the Y132F ERG11p substitution;Mycoses;2024-03

5. First Canadian report of transmission of fluconazole-resistant Candida parapsilosis within two hospital networks confirmed by genomic analysis;Journal of Clinical Microbiology;2024-01-17